ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Gross of the placeholder expense ratio and trading costs · not investor results
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1AAPL | APPLE INC | Technology | $5.16T | 23.10% |
2NVDA | NVIDIA CORP | Technology | $4.01T | 17.94% |
3AVGO | BROADCOM INC | Technology | $1.74T | 7.79% |
4LLY | ELI LILLY & CO | Healthcare | $1.34T | 6.01% |
5V | VISA INC | Financial Services | $783.16B | 3.51% |
6JNJ | JOHNSON & JOHNSON | Healthcare | $682.52B | 3.06% |
7MA | MASTERCARD INC | Financial Services | $568.53B | 2.55% |
8ABBV | ABBVIE INC | Healthcare | $520.47B | 2.33% |
9MRK | MERCK & CO INC | Healthcare | $362.27B | 1.62% |
10GE | GE AEROSPACE | Industrials | $341.89B | 1.53% |
11LRCX | LAM RESEARCH CORP | Technology | $292.03B | 1.31% |
12TXN | TEXAS INSTRUMENTS INC | Technology | $285.53B | 1.28% |
13NFLX | NETFLIX INC | Communication Services | $257.43B | 1.15% |
14AMGN | AMGEN INC | Healthcare | $252.64B | 1.13% |
15GEV | GE VERNOVA INC | Utilities | $216.64B | 0.97% |
16GILD | GILEAD SCIENCES INC | Healthcare | $208.31B | 0.93% |
17KLAC | KLA CORP | Technology | $204.96B | 0.92% |
18ADI | ANALOG DEVICES INC | Technology | $198.33B | 0.89% |
19QCOM | QUALCOMM INC | Technology | $189.54B | 0.85% |
20ABT | ABBOTT LABORATORIES | Healthcare | $185.75B | 0.83% |
21CRM | SALESFORCE INC | Technology | $179.06B | 0.80% |
22PFE | PFIZER INC | Healthcare | $164.33B | 0.74% |
23ISRG | INTUITIVE SURGICAL INC | Healthcare | $152.49B | 0.68% |
24SCCO | SOUTHERN COPPER CORP | Basic Materials | $142.03B | 0.64% |
25VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | $137.57B | 0.62% |
26SNDK | SANDISK CORP | Technology | $133.39B | 0.60% |
27APP | APPLOVIN CORP | Technology | $130.43B | 0.58% |
28BMY | BRISTOL MYERS SQUIBB CO | Healthcare | $127.39B | 0.57% |
29BKNG | BOOKING HOLDINGS INC | Consumer Cyclical | $119.88B | 0.54% |
30NEM | NEWMONT CORP | Basic Materials | $117.05B | 0.52% |
31WDC | WESTERN DIGITAL CORP | Technology | $116.49B | 0.52% |
32HCA | HCA HEALTHCARE INC | Healthcare | $104.58B | 0.47% |
33REGN | REGENERON PHARMACEUTICALS INC | Healthcare | $98.40B | 0.44% |
34MMM | 3M CO | Industrials | $96.24B | 0.43% |
35MRNA | MODERNA INC | Healthcare | $93.61B | 0.42% |
36ADBE | ADOBE INC | Technology | $92.84B | 0.42% |
37BX | BLACKSTONE INC | Financial Services | $89.04B | 0.40% |
38MCO | MOODYS CORP | Financial Services | $87.33B | 0.39% |
39FCX | FREEPORT-MCMORAN INC | Basic Materials | $86.74B | 0.39% |
40ITW | ILLINOIS TOOL WORKS INC | Industrials | $81.49B | 0.37% |
41ORLY | O REILLY AUTOMOTIVE INC | Consumer Cyclical | $73.44B | 0.33% |
42MPWR | MONOLITHIC POWER SYSTEMS INC | Technology | $70.59B | 0.32% |
43IDXX | IDEXX LABORATORIES INC | Healthcare | $54.99B | 0.25% |
44TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Healthcare | $50.93B | 0.23% |
45ONC | BEONE MEDICINES LTD | Healthcare | $47.50B | 0.21% |
46MSCI | MSCI INC | Financial Services | $46.58B | 0.21% |
47WDAY | WORKDAY INC | Technology | $45.94B | 0.21% |
48CMG | CHIPOTLE MEXICAN GRILL INC | Consumer Cyclical | $44.49B | 0.20% |
49YUM | YUM BRANDS INC | Consumer Cyclical | $42.74B | 0.19% |
50UI | UBIQUITI INC | Technology | $41.32B | 0.19% |
51RPRX | ROYALTY PHARMA PLC | Healthcare | $39.56B | 0.18% |
52TEAM | ATLASSIAN CORP | Technology | $38.35B | 0.17% |
53CCI | CROWN CASTLE INC | Real Estate | $38.16B | 0.17% |
54BIIB | BIOGEN INC | Healthcare | $37.03B | 0.17% |
55MLM | MARTIN MARIETTA MATERIALS INC | Basic Materials | $36.79B | 0.16% |
56TKO | TKO GROUP HOLDINGS INC | Communication Services | $36.60B | 0.16% |
57VMC | VULCAN MATERIALS CO | Basic Materials | $35.96B | 0.16% |
58MTD | METTLER TOLEDO INTERNATIONAL INC | Healthcare | $34.43B | 0.15% |
59ZTS | ZOETIS INC | Healthcare | $33.71B | 0.15% |
60RMD | RESMED INC | Healthcare | $33.60B | 0.15% |
61DXCM | DEXCOM INC | Healthcare | $30.35B | 0.14% |
62WSM | WILLIAMS SONOMA INC | Consumer Cyclical | $29.49B | 0.13% |
63OTIS | OTIS WORLDWIDE CORP | Industrials | $29.37B | 0.13% |
64ROIV | ROIVANT SCIENCES LTD | Healthcare | $28.98B | 0.13% |
65VRSN | VERISIGN INC | Technology | $28.03B | 0.13% |
66VRSK | VERISK ANALYTICS INC | Industrials | $26.47B | 0.12% |
67TPR | TAPESTRY INC | Consumer Cyclical | $26.06B | 0.12% |
68INSM | INSMED INC | Healthcare | $25.90B | 0.12% |
69UTHR | UNITED THERAPEUTICS CORP | Healthcare | $25.27B | 0.11% |
70EXPD | EXPEDITORS INTERNATIONAL OF WASHINGTON INC | Industrials | $25.26B | 0.11% |
71VTRS | VIATRIS INC | Healthcare | $23.70B | 0.11% |
72PTC | PTC INC | Technology | $21.29B | 0.10% |
73ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | $20.98B | 0.09% |
74WWD | WOODWARD INC | Industrials | $19.60B | 0.09% |
75ROL | ROLLINS INC | Consumer Cyclical | $18.12B | 0.08% |
76NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | $17.15B | 0.08% |
77EXEL | EXELIXIS INC | Healthcare | $17.04B | 0.08% |
78MAS | MASCO CORP | Industrials | $16.29B | 0.07% |
79JAZZ | JAZZ PHARMACEUTICALS PLC | Healthcare | $15.43B | 0.07% |
80NVR | NVR INC | Consumer Cyclical | $15.38B | 0.07% |
81BBIO | BRIDGEBIO PHARMA INC | Healthcare | $15.23B | 0.07% |
82CSL | CARLISLE COMPANIES INC | Industrials | $15.17B | 0.07% |
83DOCU | DOCUSIGN INC | Technology | $14.98B | 0.07% |
84MANH | MANHATTAN ASSOCIATES INC | Technology | $14.89B | 0.07% |
85CDE | COEUR MINING INC | Basic Materials | $14.61B | 0.07% |
86LOGI | LOGITECH INTERNATIONAL SA | Technology | $14.27B | 0.06% |
87CART | INSTACART (MAPLEBEAR INC) | Consumer Cyclical | $13.84B | 0.06% |
88COKE | COCA-COLA CONSOLIDATED INC | Consumer Defensive | $13.78B | 0.06% |
89GDDY | GODADDY INC | Technology | $13.62B | 0.06% |
90ELAN | ELANCO ANIMAL HEALTH INC | Healthcare | $13.25B | 0.06% |
91GWRE | GUIDEWIRE SOFTWARE INC | Technology | $13.12B | 0.06% |
92SEIC | SEI INVESTMENTS CO | Financial Services | $12.92B | 0.06% |
93JKHY | JACK HENRY & ASSOCIATES INC | Technology | $12.26B | 0.05% |
94IT | GARTNER INC | Technology | $12.04B | 0.05% |
95GGG | GRACO INC | Industrials | $11.62B | 0.05% |
96HALO | HALOZYME THERAPEUTICS INC | Healthcare | $11.48B | 0.05% |
97TECH | BIO-TECHNE CORP | Healthcare | $11.44B | 0.05% |
98DECK | DECKERS OUTDOOR CORP | Consumer Cyclical | $11.28B | 0.05% |
99EVR | EVERCORE INC | Financial Services | $11.22B | 0.05% |
100PAYC | PAYCOM SOFTWARE INC | Technology | $11.21B | 0.05% |
101BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $10.98B | 0.05% |
102PINS | PINTEREST INC | Communication Services | $10.97B | 0.05% |
103DPZ | DOMINOS PIZZA INC | Consumer Cyclical | $10.96B | 0.05% |
104RGEN | REPLIGEN CORP | Healthcare | $10.64B | 0.05% |
105HUBS | HUBSPOT INC | Technology | $10.54B | 0.05% |
106PODD | INSULET CORP | Healthcare | $10.36B | 0.05% |
107MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | $9.88B | 0.04% |
108CPT | CAMDEN PROPERTY TRUST | Real Estate | $9.85B | 0.04% |
109HNGE | HINGE HEALTH INC | Healthcare | $9.83B | 0.04% |
110AYI | ACUITY INC (DE) | Industrials | $9.81B | 0.04% |
111TGTX | TG THERAPEUTICS INC | Healthcare | $9.76B | 0.04% |
112DKNG | DRAFTKINGS INC | Consumer Cyclical | $9.53B | 0.04% |
113MORN | MORNINGSTAR INC | Financial Services | $9.13B | 0.04% |
114KRYS | KRYSTAL BIOTECH INC | Healthcare | $9.06B | 0.04% |
115HL | HECLA MINING CO | Basic Materials | $8.97B | 0.04% |
116PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | $8.77B | 0.04% |
117CORT | CORCEPT THERAPEUTICS INC | Healthcare | $8.07B | 0.04% |
118ALKS | ALKERMES PLC | Healthcare | $7.89B | 0.04% |
119RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | $7.62B | 0.03% |
120ETSY | ETSY INC | Consumer Cyclical | $7.61B | 0.03% |
121KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | Healthcare | $7.56B | 0.03% |
122AMRX | AMNEAL PHARMACEUTICALS INC | Healthcare | $7.56B | 0.03% |
123DBX | DROPBOX INC | Technology | $7.49B | 0.03% |
124TWST | TWIST BIOSCIENCE CORP | Healthcare | $7.16B | 0.03% |
125CHE | CHEMED CORP | Healthcare | $7.16B | 0.03% |
126CVLT | COMMVAULT SYSTEMS INC | Technology | $6.80B | 0.03% |
127RIOT | RIOT PLATFORMS INC | Financial Services | $6.69B | 0.03% |
128MP | MP MATERIALS CORP | Basic Materials | $6.68B | 0.03% |
129LNTH | LANTHEUS HOLDINGS INC | Healthcare | $6.62B | 0.03% |
130FLR | FLUOR CORP | Industrials | $6.35B | 0.03% |
131LGND | LIGAND PHARMACEUTICALS INC | Healthcare | $6.33B | 0.03% |
132MIDD | MIDDLEBY CORP | Industrials | $6.12B | 0.03% |
133TFX | TELEFLEX INC | Healthcare | $6.07B | 0.03% |
134CRUS | CIRRUS LOGIC INC | Technology | $6.07B | 0.03% |
135KVYO | KLAVIYO INC | Technology | $6.01B | 0.03% |
136BOX | BOX INC | Technology | $5.99B | 0.03% |
137DOCS | DOXIMITY INC | Healthcare | $5.92B | 0.03% |
138MKTX | MARKETAXESS HOLDINGS INC | Financial Services | $5.81B | 0.03% |
139SSRM | SSR MINING INC | Basic Materials | $5.38B | 0.02% |
140INSW | INTERNATIONAL SEAWAYS INC | Energy | $5.35B | 0.02% |
141PTCT | PTC THERAPEUTICS INC | Healthcare | $5.29B | 0.02% |
142PEGA | PEGASYSTEMS INC | Technology | $5.24B | 0.02% |
143KRG | KITE REALTY GROUP TRUST | Real Estate | $5.09B | 0.02% |
144EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | $5.02B | 0.02% |
145ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | Healthcare | $4.77B | 0.02% |
146FHI | FEDERATED HERMES INC | Financial Services | $4.70B | 0.02% |
147PIPR | PIPER SANDLER COMPANIES | Financial Services | $4.65B | 0.02% |
148IONS | IONIS PHARMACEUTICALS INC | Healthcare | $4.55B | 0.02% |
149PLNT | PLANET FITNESS INC | Consumer Cyclical | $4.48B | 0.02% |
150BMI | BADGER METER INC | Technology | $4.39B | 0.02% |
151MC | MOELIS & CO | Financial Services | $4.37B | 0.02% |
152WING | WINGSTOP INC | Consumer Cyclical | $4.31B | 0.02% |
153TENB | TENABLE HOLDINGS INC | Technology | $4.29B | 0.02% |
154MDU | MDU RESOURCES GROUP INC | Industrials | $4.17B | 0.02% |
155CRSP | CRISPR THERAPEUTICS AG | Healthcare | $4.13B | 0.02% |
156EXPO | EXPONENT INC | Industrials | $4.10B | 0.02% |
157OLED | UNIVERSAL DISPLAY CORP | Technology | $4.05B | 0.02% |
158GNTX | GENTEX CORP | Consumer Cyclical | $3.98B | 0.02% |
159NP | NEPTUNE INSURANCE HOLDINGS INC | Financial Services | $3.94B | 0.02% |
160CNS | COHEN & STEERS INC | Financial Services | $3.67B | 0.02% |
161OGN | ORGANON & CO | Healthcare | $3.65B | 0.02% |
162INTA | INTAPP INC | Technology | $3.52B | 0.02% |
163ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | $3.48B | 0.02% |
164DAVE | DAVE INC | Technology | $3.42B | 0.02% |
165FIZZ | NATIONAL BEVERAGE CORP | Consumer Defensive | $3.39B | 0.02% |
166USLM | UNITED STATES LIME & MINERALS INC | Basic Materials | $3.28B | 0.01% |
167KNF | KNIFE RIVER CORP | Basic Materials | $3.22B | 0.01% |
168BSM | BLACK STONE MINERALS LP | Energy | $3.20B | 0.01% |
169ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | $3.14B | 0.01% |
170AB | ALLIANCEBERNSTEIN HOLDING LP | Financial Services | $3.09B | 0.01% |
171APAM | ARTISAN PARTNERS ASSET MANAGEMENT INC | Financial Services | $3.09B | 0.01% |
172BHC | BAUSCH HEALTH COMPANIES INC | Healthcare | $3.09B | 0.01% |
173OSIS | OSI SYSTEMS INC | Technology | $3.08B | 0.01% |
174CARG | CARGURUS INC | Consumer Cyclical | $3.06B | 0.01% |
175XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | $3.04B | 0.01% |
176LOPE | GRAND CANYON EDUCATION INC | Consumer Defensive | $3.00B | 0.01% |
177ADMA | ADMA BIOLOGICS INC | Healthcare | $2.94B | 0.01% |
178VCEL | VERICEL CORP | Healthcare | $2.93B | 0.01% |
179XNCR | XENCOR INC | Healthcare | $2.86B | 0.01% |
180YETI | YETI HOLDINGS INC | Consumer Cyclical | $2.80B | 0.01% |
181CXW | CORECIVIC INC | Industrials | $2.72B | 0.01% |
182PGNY | PROGYNY INC | Healthcare | $2.69B | 0.01% |
183GRND | GRINDR INC | Technology | $2.55B | 0.01% |
184BEAM | BEAM THERAPEUTICS INC | Healthcare | $2.49B | 0.01% |
185NEOG | NEOGEN CORP | Healthcare | $2.44B | 0.01% |
186AD | ARRAY DIGITAL INFRASTRUCTURE INC | Communication Services | $2.36B | 0.01% |
187SDGR | SCHRODINGER INC | Healthcare | $2.32B | 0.01% |
188PRGO | PERRIGO CO PLC | Healthcare | $2.25B | 0.01% |
189ASAN | ASANA INC | Technology | $2.21B | 0.01% |
190AMPL | AMPLITUDE INC | Technology | $2.21B | 0.01% |
191AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | $2.17B | 0.01% |
192PBH | PRESTIGE CONSUMER HEALTHCARE INC | Healthcare | $2.15B | 0.01% |
193SUPN1 | SUPERNUS PHARMACEUTICALS INC | Healthcare | $2.11B | 0.01% |
194CALX | CALIX INC | Technology | $2.02B | 0.01% |
195MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | Healthcare | $2.00B | 0.01% |
196HRMY | HARMONY BIOSCIENCES HOLDINGS INC | Healthcare | $1.98B | 0.01% |
197BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $1.98B | 0.01% |
198TRLV | TRULIEVE CANNABIS CORP | Healthcare | $1.90B | 0.01% |
199AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | $1.90B | 0.01% |
200ZYME | ZYMEWORKS INC | Healthcare | $1.83B | 0.01% |
201PRKS | UNITED PARKS & RESORTS INC | Consumer Cyclical | $1.82B | 0.01% |
202ETON | ETON PHARMACEUTICALS INC | Healthcare | $1.77B | 0.01% |
203CLSK | CLEANSPARK INC | Financial Services | $1.76B | 0.01% |
204VOYG | VOYAGER TECHNOLOGIES INC | Industrials | $1.73B | 0.01% |
205SRPT | SAREPTA THERAPEUTICS INC | Healthcare | $1.72B | 0.01% |
206RARE | ULTRAGENYX PHARMACEUTICAL INC | Healthcare | $1.66B | 0.01% |
207ANIP | ANI PHARMACEUTICALS INC | Healthcare | $1.62B | 0.01% |
208IMCR | IMMUNOCORE HOLDINGS PLC | Healthcare | $1.57B | 0.01% |
209RAPP | RAPPORT THERAPEUTICS INC | Healthcare | $1.53B | 0.01% |
210PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.46B | 0.01% |
211NVAX | NOVAVAX INC | Healthcare | $1.45B | 0.01% |
212PAHC | PHIBRO ANIMAL HEALTH CORP | Healthcare | $1.44B | 0.01% |
213ANAB | ANAPTYSBIO INC | Healthcare | $1.43B | 0.01% |
214IBTA | IBOTTA INC | Technology | $1.36B | 0.01% |
215TRS | TRIMAS CORP | Consumer Cyclical | $1.35B | 0.01% |
216INVA | INNOVIVA INC | Healthcare | $1.35B | 0.01% |
217INBX | INHIBRX BIOSCIENCES INC | Healthcare | $1.29B | 0.01% |
218PD | PAGERDUTY INC | Technology | $1.24B | 0.01% |
219AMPH | AMPHASTAR PHARMACEUTICALS INC | Healthcare | $1.23B | 0.01% |
220BRBR | BELLRING BRANDS INC | Consumer Defensive | $1.19B | 0.01% |
221HLIT | HARMONIC INC | Technology | $1.13B | 0.01% |
222YELP | YELP INC | Communication Services | $1.10B | 0.00% |
223IRMD | IRADIMED CORP | Healthcare | $1.09B | 0.00% |
224HROW | HARROW INC | Healthcare | $1.06B | 0.00% |
225CYRX | CRYOPORT INC | Industrials | $1.02B | 0.00% |
226CMP | COMPASS MINERALS INTERNATIONAL INC | Basic Materials | $968M | 0.00% |
227RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | $860M | 0.00% |
228SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | $859M | 0.00% |
229TASK | TASKUS INC | Technology | $826M | 0.00% |
230COLL | COLLEGIUM PHARMACEUTICAL INC | Healthcare | $775M | 0.00% |
231YEXT | YEXT INC | Technology | $757M | 0.00% |
232MUX | MCEWEN INC | Basic Materials | $736M | 0.00% |
233QDEL | QUIDELORTHO CORP | Healthcare | $729M | 0.00% |
234JANX | JANUX THERAPEUTICS INC | Healthcare | $703M | 0.00% |
235AESI | ATLAS ENERGY SOLUTIONS INC | Energy | $689M | 0.00% |
236KURA | KURA ONCOLOGY INC | Healthcare | $683M | 0.00% |
237SGMT | SAGIMET BIOSCIENCES INC | Healthcare | $679M | 0.00% |
238ZVRA | ZEVRA THERAPEUTICS INC | Healthcare | $664M | 0.00% |
239DNA | GINKGO BIOWORKS HOLDINGS INC | Healthcare | $663M | 0.00% |
240CGEM | CULLINAN THERAPEUTICS INC | Healthcare | $662M | 0.00% |
241NRC | NRC HEALTH | Healthcare | $565M | 0.00% |
242MYGN | MYRIAD GENETICS INC | Healthcare | $545M | 0.00% |
243TKNO | ALPHA TEKNOVA INC | Healthcare | $522M | 0.00% |
244IIIV | I3 VERTICALS INC | Technology | $491M | 0.00% |
245EOLS | EVOLUS INC | Healthcare | $475M | 0.00% |
246NRDS | NERDWALLET INC | Communication Services | $463M | 0.00% |
247ARVN | ARVINAS INC | Healthcare | $450M | 0.00% |
248ETD | ETHAN ALLEN INTERIORS INC | Consumer Cyclical | $446M | 0.00% |
249IPI | INTREPID POTASH INC | Basic Materials | $446M | 0.00% |
250PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $423M | 0.00% |
251PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | $418M | 0.00% |
252NVEC | NVE CORP | Technology | $400M | 0.00% |
253LYEL | LYELL IMMUNOPHARMA INC | Healthcare | $385M | 0.00% |
254PEPG | PEPGEN INC | Healthcare | $349M | 0.00% |
255HCKT | HACKETT GROUP INC | Technology | $333M | 0.00% |
256FLXS | FLEXSTEEL INDUSTRIES INC | Consumer Cyclical | $313M | 0.00% |
257EBS | EMERGENT BIOSOLUTIONS INC | Healthcare | $303M | 0.00% |
258TBCH | TURTLE BEACH CORP | Technology | $296M | 0.00% |
259FTH | FAETH THERAPEUTICS INC | Healthcare | $275M | 0.00% |
260DMAA | DRUGS MADE IN AMERICA ACQUISITION CORP | Financial Services | $265M | 0.00% |
261ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $243M | 0.00% |
262LFCR | LIFECORE BIOMEDICAL INC | Healthcare | $243M | 0.00% |
263USNA | USANA HEALTH SCIENCES INC | Consumer Defensive | $235M | 0.00% |
264MSB | MESABI TRUST | Basic Materials | $225M | 0.00% |
265TDAC | TRANSLATIONAL DEVELOPMENT ACQUISITION CORP | Financial Services | $210M | 0.00% |
266ELMD | ELECTROMED INC | Healthcare | $204M | 0.00% |
267TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $202M | 0.00% |
268RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | $194M | 0.00% |
269ANIK | ANIKA THERAPEUTICS INC | Healthcare | $185M | 0.00% |
270NATR | NATURES SUNSHINE PRODUCTS INC | Consumer Defensive | $178M | 0.00% |
271KVHI | KVH INDUSTRIES INC | Communication Services | $134M | 0.00% |
272SAMG | SILVERCREST ASSET MANAGEMENT GROUP INC | Financial Services | $132M | 0.00% |
273QSEA | QUARTZSEA ACQUISITION CORP | Financial Services | $109M | 0.00% |
274CPIX | CUMBERLAND PHARMACEUTICALS INC | Healthcare | $99M | 0.00% |
275ICCC | IMMUCELL CORP | Healthcare | $93M | 0.00% |
276JYNT | JOINT CORP | Healthcare | $92M | 0.00% |
277RLYB | RALLYBIO CORP | Healthcare | $84M | 0.00% |
278VTVT | VTV THERAPEUTICS INC | Healthcare | $83M | 0.00% |
279FTLF | FITLIFE BRANDS INC | Consumer Defensive | $78M | 0.00% |
280LFVN | LIFEVANTAGE CORP | Consumer Defensive | $64M | 0.00% |
281CAPN | CAYSON ACQUISITION CORP | Financial Services | $61M | 0.00% |
282YARW | YARROW BIOSCIENCE INC | Healthcare | $52M | 0.00% |
Full long-leg book as of November 2026 · cap-weighted · total market cap $22.32T. Hypothetical model holdings — not a registered fund’s portfolio.
Size × value map of the long-leg book
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Days required to liquidate the largest position at 20% of one day's dollar volume.
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20261113T032607 rows=2198308 asof=202611 issuers=20261113T063725 rates=20261113T063725
Measured on the 2026-11 formation date across 282 holdings (cap-weighted). A different formation date can produce different verdicts.
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 335 monthly observations · about 3.4 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 16.2% | 32.6% |
| 3 yearsp.a. | 27.9% | 7.7% |
| 5 yearsp.a. | 18.1% | 17.2% |
| 10 yearsp.a. | 20.1% | 7.7% |
| Since inceptionp.a. | 11.0% | 2.0% |
| Year | Long leg | Long-short |
|---|---|---|
| 202611 mo | 15.0% | 30.9% |
| 2025 | 26.3% | -6.3% |
| 2024 | 37.4% | 5.0% |
| 2023 | 38.5% | 7.7% |
| 2022 | -21.2% | 40.0% |
| 2021 | 30.7% | 55.3% |
| 2020 | 28.0% | -45.7% |
| 2019 | 34.3% | 8.4% |
| 2018 | -0.2% | 14.7% |
| 2017 | 25.8% | 2.2% |
| 2016 | 4.8% | 3.1% |
| 2015 | 4.3% | 10.4% |
| 2014 | 19.6% | 10.7% |
| 2013 | 35.2% | -6.9% |
| 2012 | 12.2% | -0.4% |
| 2011 | 8.8% | 7.2% |
| 2010 | 10.9% | -10.1% |
| 2009 | 23.4% | -15.5% |
| 2008 | -24.2% | 41.5% |
| 2007 | 9.9% | 2.8% |
| 2006 | 13.1% | -1.2% |
| 2005 | 3.4% | -13.3% |
| 2004 | 3.1% | -15.6% |
| 2003 | 24.7% | -13.3% |
| 2002 | -22.1% | 13.5% |
| 2001 | -3.0% | 34.7% |
| 2000 | -7.3% | 21.4% |
| 1999 | 16.0% | -48.1% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through November 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
The Foundry NetEqFin Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a NetEqFin signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,140-name universe at November 2026. Rows: Large ≥ $5.3B, Small < $832M. Columns: Value ≥ 0.62, Growth < 0.33 B/M. The dot marks the capital-weighted centroid of the book — 99% toward Large, 92% toward Growth. +1% unclassified (25 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → November 2026; the right-hand end is the same value as the box’s dot. 282 names now. Hypothetical holdings — descriptive, not P&L.